Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 28 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistantFrost, M.; Ferrao, P.; Hughes, T.; Ashman, L.
2002Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-a signalingXia, P.; Wang, L.; Moretti, P.; Albanese, N.; Chai, F.; Pitson, S.; D'Andrea, R.; Gamble, J.; Vadas, M.
1996Interleukin-1β-converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killingSong, Q.; Burrows, S.; Smith, G.; Lees-Miller, S.; Kumar, S.; Chan, D.; Trapani, J.; Alnemri, E.; Litwack, G.; Lu, H.; Moss, D.; Jackson, S.; Lavin, M.
2017Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancerMishra, A.; Parish, C.; Wong, M.; Licinio, J.; Blackburn, A.; Ahmad, A.
2014Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinomaAl-Ejeh, F.; Pajic, M.; Shi, W.; Kalimutho, M.; Miranda, M.; Nagrial, A.; Chou, A.; Biankin, A.; Grimmond, S.; Brown, M.; Khanna, K.
2017The combination of metformin and valproic acid induces synergistic apoptosis in the presence of p53 and androgen signaling in prostate cancerTran, L.N.; Kichenadasse, G.; Butler, L.M.; Centenera, M.M.; Morel, K.L.; Ormsby, R.J.; Michael, M.Z.; Lower, K.M.; Sykes, P.J.
2018The Mitochondrial Apoptotic Effectors BAX/BAK Activate Caspase-3 and -7 to Trigger NLRP3 Inflammasome and Caspase-8 Driven IL-1β ActivationVince, J.E.; De Nardo, D.; Gao, W.; Vince, A.J.; Hall, C.; McArthur, K.; Simpson, D.; Vijayaraj, S.; Lindqvist, L.M.; Bouillet, P.; Rizzacasa, M.A.; Man, S.M.; Silke, J.; Masters, S.L.; Lessene, G.; Huang, D.C.S.; Gray, D.H.D.; Kile, B.T.; Shao, F.; Lawlor, K.E.
2019Autophagy-dependent cell deathDenton, D.; Kumar, S.
2018Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosisTvorogov, D.; Thomas, D.; Liau, N.P.D.; Dottore, M.; Barry, E.F.; Lathi, M.; Kan, W.L.; Hercus, T.R.; Stomski, F.; Hughes, T.P.; Tergaonkar, V.; Parker, M.W.; Ross, D.M.; Majeti, R.; Babon, J.J.; Lopez, A.F.
2015Essential versus accessory aspects of cell death: recommendations of the NCCD 2015Galluzzi, L.; Bravo-San Pedro, J.; Vitale, I.; Aaronson, S.; Abrams, J.; Adam, D.; Alnemri, E.; Altucci, L.; Andrews, D.; Annicchiarico-Petruzzelli, M.; Baehrecke, E.; Bazan, N.; Bertrand, M.; Bianchi, K.; Blagosklonny, M.; Blomgren, K.; Borner, C.; Bredesen, D.; Brenner, C.; Campanella, M.; et al.